MyAverix Finance
US · Healthcare
Amylyx Pharmaceuticals Inc (AMLX)
Drug Manufacturers - Specialty & Generic
Amylyx Pharmaceuticals Inc (AMLX) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AMLX
Amylyx Pharmaceuticals Inc (AMLX) — FAQ
What is AMLX's P/E ratio?
The price-to-earnings (P/E) ratio for Amylyx Pharmaceuticals Inc (AMLX) is 18.00 (data as of 2026-05-23).
Does Amylyx Pharmaceuticals Inc pay a dividend?
Dividend yield is not available in the current snapshot for Amylyx Pharmaceuticals Inc (AMLX). Check the MyAverix Finance app for the latest dividend data.
What sector is Amylyx Pharmaceuticals Inc in?
Amylyx Pharmaceuticals Inc (AMLX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is AMLX listed on?
AMLX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.